The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Girolamo Ranieri

Interventional Radiology Unit with Integrated Section of Translational Medical Oncology

National Cancer Centre "Giovanni Paolo II" Bari

Italy

[email]@tiscalinet.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Interventional Radiology Unit with Integrated Section of Translational Medical Oncology, National Cancer Centre "Giovanni Paolo II" Bari, Italy. 2012
  • Department of Critical Area and Surery, National Cancer Institute Giovanni Paolo II, 70126 Bari, Italy. 2004 - 2009
  • Clinical and Experimental Oncology Laboratory, National Cancer Insitute of Bari, Italy. 2001 - 2006
  • National Cancer Institute, Interventional Radiology Unit, Bari 70126, Italy. 2003

References

  1. Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development. Ranieri, G., Gadaleta-Caldarola, G., Goffredo, V., Patruno, R., Mangia, A., Rizzo, A., Sciorsci, R.L., Gadaleta, C.D. Curr. Med. Chem. (2012) [Pubmed]
  2. Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. Ranieri, G., Ammendola, M., Patruno, R., Celano, G., Zito, F.A., Montemurro, S., Rella, A., Di Lecce, V., Gadaleta, C.D., Battista De Sarro, G., Ribatti, D. Int. J. Oncol. (2009) [Pubmed]
  3. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Ranieri, G., Patruno, R., Ruggieri, E., Montemurro, S., Valerio, P., Ribatti, D. Curr. Med. Chem. (2006) [Pubmed]
  4. Drug targets to pro-angiogenetic factors with special reference to primary peritoneal mesothelioma. Ranieri, G., Ruggieri, E., Falco, G., Zizzo, N., Mattioli, E., Zito, A.F., Patruno, R., Gasparini, G. Endocrine,. Metabolic. &. Immune. Disorders. Drug. Targets (2006) [Pubmed]
  5. Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls. Ranieri, G., Coviello, M., Chiriatti, A., Stea, B., Montemurro, S., Quaranta, M., Dittadi, R., Paradiso, A. Oncol. Rep. (2004) [Pubmed]
  6. Vascular endothelial growth factor concentrations in the plasma-activated platelets rich (P-APR) of healthy controls and colorectal cancer patients. Ranieri, G., Coviello, M., Patruno, R., Valerio, P., Martino, D., Milella, P., Catalano, V., Scotto, F., De Ceglie, A., Quaranta, M., Ribatti, D., Pellecchia, A. Oncol. Rep. (2004) [Pubmed]
  7. The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Ranieri, G., Passantino, L., Patruno, R., Passantino, G., Jirillo, F., Catino, A., Mattioli, V., Gadaleta, C., Ribatti, D. Oncol. Rep. (2003) [Pubmed]
  8. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy. Ranieri, G., Gasparini, G. Curr. Drug Targets Immune Endocr. Metabol. Disord. (2001) [Pubmed]
 
WikiGenes - Universities